Results 101 to 110 of about 1,738 (143)

Altered PTPN13-β-catenin interaction by pathogenic mutations and involvement of this axis in B-cell receptor signalling. [PDF]

Sci Rep
Cabrera-Riofrío DA, Li H, García-Calvo C, Sánchez-Bernal C, Sánchez-Yagüe J, Dror Y, Buey RM, Hernández-Hernández Á.   +7 more
europepmc   +1 more source

Real-world overall survival comparison between first-line Bruton tyrosine kinase inhibitors in treating chronic lymphocytic leukemia/small lymphocytic lymphoma: An analysis of Veterans Health Administration data. [PDF]

J Manag Care Spec Pharm
Fitzgerald L, Ghosh S, Khan W, Bokun A, Lax A, Mu F, Cook EE, Chen J, Chen G, Wu E, Lin Y, Shi L, Qureshi ZP, Graf SA.   +13 more
europepmc   +1 more source

Phosphorylation-Inducing Molecules for Regulating Dynamic Cellular Processes. [PDF]

J Am Chem Soc
Pergu R, Sreekanth V, Kokkonda P, Lai S, Tiwari PK, Singh S, Kawai J, Singha S, Tian W, Thimaradka V, Siriwongsup S, Tran K, Choudhary A.   +12 more
europepmc   +1 more source

BTK-Inhibition Enhances TLR-7-Mediated Interferon-Alpha Production in pDCs by Blocking the Inhibitory BDCA-2 Pathway. [PDF]

Eur J Immunol
Ceglarek L, Gerhards R, Boldrini V, Wichmann C, Peters A, Meinl E.   +5 more
europepmc   +1 more source

Molecular insight on the role of the phosphoinositide PIP3 in regulating the protein kinases Akt, PDK1, and BTK. [PDF]

Biochem Soc Trans
Shaw AL, Burke JE.
europepmc   +1 more source

Modulating the Binding Kinetics of Bruton's Tyrosine Kinase Inhibitors through Transition-State Effects. [PDF]

J Am Chem Soc
Bravo E, Li Y, Lin DY, Srinivasan B, Barone M, Li SX, DelloRusso F, Rahiyanath AS, Corrionero A, Alfonso P, Prendiville N, Kozakov D, Andreotti AH, Tonge PJ.   +13 more
europepmc   +1 more source

Membrane-dependent assembly of Bruton's tyrosine kinase mediated by the Proline-rich region and SH3 domain. [PDF]

Protein Sci
Fenton AD, Chung JK.
europepmc   +1 more source

Establishment and Validation of a UPLC-MS/MS Method for Quantitative Determination of Zanubrutinib and Posaconazole in Rat Plasma: Application in Drug-Drug Interaction Studies. [PDF]

Drug Des Devel Ther
Xia H, Shen Y, Xu X, Wu J, Lin G, Du X.
europepmc   +1 more source

In silico analysis of atrial fibrillation and hypertension mechanism of action secondary to ibrutinib/acalabrutinib in chronic lymphocytic leukemia. [PDF]

Sci Rep
Córdoba R, Bayés-Genís A, Muntañola A, Colomer D, Castro J, Leiva C, Álvarez E, Zatarain-Nicolas E.   +7 more
europepmc   +1 more source

The Direction of Modern Therapies in Waldenström Macroglobulinaemia. [PDF]

J Cell Mol Med
Blackmore S, Elsawa S, Tavana O.
europepmc   +1 more source